These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 16618753
1. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, Altieri DC, Roy-Burman P. Cancer Res; 2006 Apr 15; 66(8):4285-90. PubMed ID: 16618753 [Abstract] [Full Text] [Related]
2. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. Cancer Res; 2005 Jul 01; 65(13):5769-77. PubMed ID: 15994952 [Abstract] [Full Text] [Related]
3. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Singh SV, Choi S, Zeng Y, Hahm ER, Xiao D. Cancer Res; 2007 Aug 01; 67(15):7439-49. PubMed ID: 17671214 [Abstract] [Full Text] [Related]
4. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Engedal N, Korkmaz CG, Saatcioglu F. Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819 [Abstract] [Full Text] [Related]
5. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K. Prostate; 2008 Mar 01; 68(4):427-41. PubMed ID: 18196534 [Abstract] [Full Text] [Related]
6. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H. J Endocrinol; 2008 Mar 01; 196(3):601-13. PubMed ID: 18310456 [Abstract] [Full Text] [Related]
7. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer. Arnoldussen YJ, Lorenzo PI, Pretorius ME, Waehre H, Risberg B, Maelandsmo GM, Danielsen HE, Saatcioglu F. Cancer Res; 2008 Nov 15; 68(22):9255-64. PubMed ID: 19010898 [Abstract] [Full Text] [Related]
8. Survivin mediates resistance to antiandrogen therapy in prostate cancer. Zhang M, Latham DE, Delaney MA, Chakravarti A. Oncogene; 2005 Apr 07; 24(15):2474-82. PubMed ID: 15735703 [Abstract] [Full Text] [Related]
9. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Yoo J, Lee YJ. Mol Pharmacol; 2007 Dec 07; 72(6):1586-92. PubMed ID: 17848598 [Abstract] [Full Text] [Related]
10. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH, Kumon H. Cancer Res; 2008 Oct 15; 68(20):8333-41. PubMed ID: 18922905 [Abstract] [Full Text] [Related]
11. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018 [Abstract] [Full Text] [Related]
12. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Ye L, Kynaston H, Jiang WG. Mol Cancer Res; 2008 Oct 01; 6(10):1594-606. PubMed ID: 18922975 [Abstract] [Full Text] [Related]
13. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation. Su JC, Lin KL, Chien CM, Lu CM, Chen YL, Chang LS, Lin SR. Life Sci; 2009 Sep 23; 85(13-14):505-16. PubMed ID: 19699753 [Abstract] [Full Text] [Related]
14. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G. Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715 [Abstract] [Full Text] [Related]
15. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. Joo SS, Yoo YM. J Pineal Res; 2009 Aug 15; 47(1):8-14. PubMed ID: 19522739 [Abstract] [Full Text] [Related]
16. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Pennati M, Binda M, Colella G, Zoppe' M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, Giacca M, Daidone MG, Zaffaroni N. Oncogene; 2004 Jan 15; 23(2):386-94. PubMed ID: 14724567 [Abstract] [Full Text] [Related]
17. c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Antosiewicz J, Herman-Antosiewicz A, Marynowski SW, Singh SV. Cancer Res; 2006 May 15; 66(10):5379-86. PubMed ID: 16707465 [Abstract] [Full Text] [Related]
18. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K. Apoptosis; 2006 Oct 15; 11(10):1813-23. PubMed ID: 16850165 [Abstract] [Full Text] [Related]
19. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways. Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK. Biochemistry; 2006 Mar 21; 45(11):3703-13. PubMed ID: 16533053 [Abstract] [Full Text] [Related]
20. Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Cheng Y, Chang LW, Tsou TC. Arch Toxicol; 2006 Jun 21; 80(6):310-8. PubMed ID: 16328441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]